Success Metrics

Clinical Success Rate
81.8%

Based on 9 completed trials

Completion Rate
82%(9/11)
Active Trials
0(0%)
Results Posted
33%(3 trials)
Terminated
2(13%)

Phase Distribution

Ph not_applicable
1
6%
Ph phase_1
7
44%
Ph phase_3
1
6%
Ph phase_2
3
19%
Ph phase_4
3
19%

Phase Distribution

7

Early Stage

3

Mid Stage

4

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
7(46.7%)
Phase 2Efficacy & side effects
3(20.0%)
Phase 3Large-scale testing
1(6.7%)
Phase 4Post-market surveillance
3(20.0%)
N/ANon-phased studies
1(6.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

69.2%

9 of 13 finished

Non-Completion Rate

30.8%

4 ended early

Currently Active

0

trials recruiting

Total Trials

16

all time

Status Distribution
Completed(9)
Terminated(4)
Other(3)

Detailed Status

Completed9
unknown3
Terminated2
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
16
Active
0
Success Rate
81.8%
Most Advanced
Phase 4

Trials by Phase

Phase 17 (46.7%)
Phase 23 (20.0%)
Phase 31 (6.7%)
Phase 43 (20.0%)
N/A1 (6.7%)

Trials by Status

unknown319%
completed956%
terminated213%
withdrawn213%

Recent Activity

Clinical Trials (16)

Showing 16 of 16 trials
NCT04629651Phase 1

Captopril Use on the Degree of Marrow Fibrosis in Bone Marrow Fibrosis/Myeloproliferative Neoplasms

Withdrawn
NCT04878315Phase 1

Bioequivalence Study Between Capoten Versus Captopril Reference Product in Healthy Adult Participants Under Fasting Conditions

Withdrawn
NCT02770378Phase 1

A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma

Completed
NCT01626469Phase 1

Measurement of Eye Blood Flow and Renal Function in Healthy and Diabetic Patients

Unknown
NCT03660293Not Applicable

Prediction and Prevention of Asymptomatic Cardiovascular Insult in Type 1 Diabetic Children: Comparative Effectiveness of Cardioprotective Drugs

Completed
NCT01292694Phase 1

Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure

Terminated
NCT00077064Phase 2

Captopril in Treating Patients With Non-Small Cell Lung Cancer or Limited-Stage Small Cell Lung Cancer That Has Been Previously Treated With Radiation Therapy With or Without Chemotherapy

Terminated
NCT00223717Phase 1

Treatment of Supine Hypertension in Autonomic Failure

Completed
NCT01761916Phase 4

Clonidine Versus Captopril for Treatment of Postpartum Very High Blood Pressure

Completed
NCT00660309Phase 4

A Clinical Study to Evaluate Renal Hemodynamic Responses to Aliskiren in Patients With Type 2 Diabetes Mellitus

Completed
NCT00391846Phase 4

Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone

Completed
NCT00086723Phase 1

In Vivo Angiostatin Generation Using Tissue Plasminogen Activator and Captopril in Treating Patients With Progressive Metastatic Cancer

Completed
NCT00004230Phase 3

Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation

Completed
NCT00935805

Glycemic And Blood Pressure Control In Type 2 Diabetes, In A Primary Care Unit: A Staged Management Strategy

Unknown
NCT00742040Phase 2

Rapid Versus Prolonged Inpatient Up-Titration of Captopril

Unknown
NCT00663949Phase 2

Assessment of the Effect of Captopril Versus Combination of Captopril and Pentoxifylline on Reducing Proteinuria in Type 2 Diabetic Nephropathy

Completed

All 16 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
16